Psychedelics Sector Deals 2025: AbbVie/Gilgamesh Impact and Market Outlook

In this special Flashcast edition of the WTR Small-Cap Spotlight Podcast, host Tim Gerdeman sits down with Robert Sassoon, Senior Research Analyst at Water Tower Research, to discuss the recent wave of deal activity in the psychedelics sector.Robert breaks down major transactions, including why the AbbVie/Gilgamesh deal marks a potential turning point for the industry, and what these developments could mean for sector valuations going forward.Whether you’re an investor tracking emerging growth sectors or just curious about the rapidly evolving psychedelics market, this quick-hit episode provides the essential insights you need to stay ahead.